Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
nasal spray
Manufacturing
FDA rejects Milestone’s nasal spray citing manufacturing issues
Citing two manufacturing issues, the FDA has rejected Milestone’s application for approval of etripamil, a nasal spray for a heartbeat disorder.
Kevin Dunleavy
Mar 28, 2025 8:42am
Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M
Mar 20, 2025 11:23am
Emergent launches OTC overdose drug so 'anyone can save a life'
Aug 31, 2023 9:55am
Aptar creates metal-free nasal spray pump to boost recyclability
Jan 31, 2023 11:59am
J&J builds case for Spravato in tough-to-treat depression
Nov 23, 2022 10:05am
FDA accepts ARS' filing for nasal spray EpiPen rival for review
Oct 25, 2022 10:27am
